Cite
HARVARD Citation
Klempner, S. et al. (n.d.). 262 Tumoral DKK1 expression correlates with better clinical outcomes in patients with advanced esophagogastric cancer (EGC) treated with DKN-01. Journal for immunotherapy of cancer. p. A160. [Online].